SCORE2 and SCORE2-OP
Estimate 10-year fatal and non-fatal cardiovascular event risk in apparently healthy European populations. SCORE2-OP is designed for older age groups.
PROF. DR. SİNAN ALTAN KOCAMANCARDIOLOGY SPECIALISTAccess selected tools for cardiovascular risk, rhythm disorders, cardiomyopathy, coronary disease and pre-operative assessment. Each calculator opens on the independent provider's website.
These tools do not diagnose disease, assess emergencies or make treatment decisions by themselves. Results—especially those marked “For Clinicians”—must be interpreted with examination, ECG, imaging, laboratory findings and current clinical guidance. Never start, stop or change medicine because of a calculator result.
Core tools that help explain cardiovascular and metabolic risk factors.
Estimate 10-year fatal and non-fatal cardiovascular event risk in apparently healthy European populations. SCORE2-OP is designed for older age groups.
Estimate 10- and 30-year risk of cardiovascular disease, stroke and heart failure for adults aged 30–79; PREVENT-Age also estimates cardiovascular age.
Supports assessment of 10-year cardiovascular event risk in people with type 2 diabetes.
Uses age, cholesterol, blood pressure, smoking and diabetes to estimate longer-term cardiovascular risk.
Calculates an approximate insulin-resistance index from fasting glucose and insulin. There is no single universal diagnostic threshold.
Two awareness measures that describe weight relative to height and central fat distribution. Neither measure is a diagnosis by itself.
Classifies the probability of familial hypercholesterolaemia using LDL level, family history, clinical findings and genetic results.
Clinical models for stroke, bleeding and sudden cardiac death risk that require professional interpretation.
Supports stroke and systemic embolism risk assessment in atrial fibrillation. Current guideline use of CHA₂DS₂-VA requires clinical interpretation.
Makes modifiable bleeding risk factors visible during anticoagulant therapy in atrial fibrillation; it does not decide whether treatment should be stopped.
Supports estimation of 5-year sudden cardiac death risk and ICD assessment in adults with hypertrophic cardiomyopathy.
Paediatric models used to assess sudden cardiac death risk in children and young people with hypertrophic cardiomyopathy.
Supports individual assessment of ventricular arrhythmia risk in arrhythmogenic right ventricular cardiomyopathy.
Calculates a heart-rate-corrected QT interval with Bazett, Fridericia, Framingham or Hodges formulae.
Decision-support tools for coronary artery disease, acute coronary syndromes and antiplatelet treatment.
Estimates recurrent cardiovascular event risk and potential absolute treatment benefit in people with established vascular disease.
Assesses in-hospital and follow-up risk of death or myocardial infarction in acute coronary syndromes.
Help balance bleeding and ischaemic risk when planning the duration of dual antiplatelet therapy after stenting.
Professional tools used in acute thromboembolism, medicine dosing and assessment before surgery.
Classify 30-day mortality risk in acute pulmonary embolism and support decisions about the appropriate level of care.
Support kidney-function assessment and dosing of selected medicines. The formula should be chosen for the clinical purpose.
Classifies the risk of major cardiac complications before non-cardiac surgery using six clinical variables.
Models used by cardiac surgical teams to estimate mortality and complication risk before heart surgery.
You may send a message for preliminary information on general cardiovascular topics and guidance on seeking the appropriate health service.